CAS 1089283-49-7: gsk 1904529a
Description:GSK 1904529A, with the CAS number 1089283-49-7, is a small molecule that has been primarily investigated for its potential therapeutic applications, particularly in the field of oncology and immunology. It acts as a selective inhibitor of certain kinases, which are enzymes that play crucial roles in various cellular processes, including cell growth, proliferation, and survival. The compound's mechanism of action typically involves the modulation of signaling pathways that are often dysregulated in cancerous cells. In preclinical studies, GSK 1904529A has shown promise in inhibiting tumor growth and enhancing the efficacy of other therapeutic agents. Its pharmacokinetic properties, such as absorption, distribution, metabolism, and excretion, are essential for determining its suitability for clinical use. Additionally, safety and toxicity profiles are critical factors that researchers evaluate during drug development. Overall, GSK 1904529A represents a significant area of interest in drug discovery, particularly for targeted cancer therapies.
Formula:C44H47F2N9O5S
InChI:InChI=1S/C44H47F2N9O5S/c1-5-28-26-35(38(60-3)27-36(28)53-19-15-30(16-20-53)52-21-23-54(24-22-52)61(4,57)58)49-44-47-17-14-34(48-44)42-40(50-39-11-6-7-18-55(39)42)29-12-13-37(59-2)31(25-29)43(56)51-41-32(45)9-8-10-33(41)46/h6-14,17-18,25-27,30H,5,15-16,19-24H2,1-4H3,(H,51,56)(H,47,48,49)
- Synonyms:
- Gsk 4529
- N-(2,6-Difluorophenyl)-5-(3-(2-((5-Ethyl-2-(Methyloxy)-4-(4-(4-(Methylsulfonyl)-1-Piperazinyl)-1-Piperidinyl)Phenyl)Amino)-4-Pyrimidinyl)Imidazo(1,2-A)Pyridin-2-Yl)-2-(Methyloxy)Benzamide
- Gsk1904529A
